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Abstract
Use of HIV screening/testing and prophylaxis has been found to be low in the general
emergency department (ED) population. Less is known about the use of HIV/sexually
transmitted infection (STI) screening, testing, and prophylaxis among sexual assault
survivors who present to EDs. The main research questions asked whether there was a
relationship between race, socioeconomic status (SES), geographic region, or age,
HIV/STI, treatment, and prophylaxis among sexual assault survivors that present to U.S.
EDs. This study was a secondary analysis of data collected in the NHAMCS years 2010
to 2016 and included 112 geographic primary sampling units, about 480 hospitals. The
findings of this quantitative, cross-sectional study, informed using the socioecological
framework, found that White sexual assault patients had a 3 times greater likelihood of
receiving an HIV test than Black sexual assault patients. Sexual assault patients in the
West have an 8.7 times higher lower likelihood of receiving an HIV test than do patients
in the Northeast, despite having a lower number of sexual assaults. Sexual assault
patients aged 0 to 10 have an 8 times lower likelihood of receiving appropriate HIV/STI
medications for treatment or prophylaxis than the reference group. This new knowledge
can contribute to positive social change through improved care of sexual assault patients,
a potential decrease in the rate of HIV transmission, and a decrease in social cost and
stigma. Findings from this research may promote protocols and specialized staff and
influence policy, research, law, and support of evidence-based interventions to address
the disparities outlined above.
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Dedication
To all sexual assault survivors; may you find healing, hope, and peace.

Acknowledgments
Thank you to my husband Mark T. Cita who sacrificed so that I might have the
opportunity to do this research and pursue my doctorate in Public Health. I couldn’t have
done it without your love and support.
Thank you to Dr. Sri K. Banerjee, my chair and mentor, who led me out of the
darkness and set me on the path of academic fulfillment. Your support and
encouragement made all the difference. Thanks also to my committee member Dr. J.
Khubchandani for your valuable feedback and advice.

Table of Contents
List of Tables ..................................................................................................................... iii
Section 1: Foundation of the Study and Literature Review .................................................1
Problem Statement .........................................................................................................3
Purpose of the Study ......................................................................................................4
Research Questions and Hypotheses .............................................................................5
Theoretical Foundation for the Study ..........................................................................10
Nature of the Study ......................................................................................................12
Literature Search Strategy............................................................................................13
Literature Review Related to Key Variables and/or Concepts ....................................13
Study Definitions and Assumptions.............................................................................18
Scope and Delimitations ..............................................................................................19
Significance, Summary, and Conclusions ...................................................................20
Section 2: Research Design and Data Collection ..............................................................21
Research Design and Rationale ...................................................................................21
Methodology Population ..............................................................................................21
Sampling Procedures ............................................................................................ 22
Operationalization ................................................................................................ 23
Data Analysis Plan .......................................................................................................24
Threats to Validity .......................................................................................................28
Ethical Procedures .......................................................................................................29
Summary ......................................................................................................................29
i

Section 3: Presentation of the Results and Findings ..........................................................29
Data Collection of Secondary Data Set .......................................................................35
Results and Findings ....................................................................................................36
Section 4: Application to Professional Practice and Implications for Social
Change ...................................................................................................................45
Interpretation of the Findings.......................................................................................45
Interpretation of Findings by Research Question ........................................................47
Limitations ...................................................................................................................49
Recommendations ........................................................................................................50
Implications for Professional Practice and Social Change ..........................................51
Professional Practice ............................................................................................. 51
Positive Social Change ......................................................................................... 53
Conclusion ...................................................................................................................53
References ..........................................................................................................................55

ii

List of Tables
Table 1. Percentage Participation and Unweighted Response Rate ....................................3
Table 2. Sample Age Range and Mean ..............................................................................36

Table 3. Full Sample Baseline Descriptive and Demographic Characteristics ................36

Table 4. Final Sample Racial, Socioeconomic, Geographic Region, and Age .................37
Table 5. Research Question 1: Binomial Logistic Regression Predicting Likelihood of
Receiving HIV Test Based on Race.......................................................................38
Table 6. Research Question 2: Binomial Logistic Regression Predicting Likelihood of
Receiving Urinalysis or Pelvic Exam Based on Race ...........................................39
Table 7. Research Question 3: Binomial Logistic Regression Predicting Likelihood of
Receiving Appropriate Drug Treatment or Prophylaxis Based on Race ..............39
Table 8. Research Question 4: Binomial Logistic Regression Predicting……………….39
Likelihood of Receiving HIV Test Based on Socioeconomic
Status……………………39Table 9. Research Question 5: Binomial Logistic
Regression Predicting……………….39 Likelihood of Receiving Urinalysis or
Pelvic Exam Based on Socioeconomic Status .......................................................40
Table 10. Research Question 6: Binomial Logistic Regression Predicting Likelihood of
Receiving Appropriate Drug Treatment or Prophylaxis Based on Socioeconomic
Status .....................................................................................................................40
Table 11. Research Question 7: Binomial Logistic Regression Predicting
Likelihood of Receiving HIV Test Based on Geographic Region ....................................41
iii

Table 12. Research Question 8: Binomial Logistic Regression Predicting Likelihood of
Receiving Urinalysis Based on Geographic Region ..............................................41
Table 13. Research Question 8: Binomial Logistic Regression Predicting Likelihood of
Receiving Pelvic Exam Based on Geographic Region ..........................................41
Table 14. Research Question 9: Binomial Logistic Regression Predicting Likelihood of
Receiving Appropriate Medications Based on Geographic
Region 42
Table 15. Research Question 10: Binomial Logistic Regression Predicting Likelihood of
Receiving HIV Test Based on Age Group ............................................................42
Table 16. Research Question 10: Binomial Logistic Regression Predicting Likelihood of
Receiving Urinalysis Exam Based on Age Group ............................................... 43
Table 17. Research Question 11: Binomial Logistic Regression Predicting Likelihood of
Receiving Pelvic Exam Based on Age Group ......................................................43
Table 18. Research Question 11: Binomial Logistic Regression Predicting Likelihood of
Receiving Appropriate Medications Based on Age Group ...................................43

iv

1
Section 1: Foundation of the Study and Literature Review
The surveillance and control of HIV and other sexually transmitted infections
(STIs) is a public health priority in the United States (Centers for Disease Control and
Prevention [CDC], 2018). Although this has resulted in an 11.7% decrease in HIV
infections since 2010, there are still opportunities for improvement. In 2015, there were a
total of 38,500 new cases of HIV estimated in the United States, with a prevalence of
418.7 per 100,000 and incidence of 7.9% (CDC, 2018). Other STIs are increasing. In
2015, the prevalence of chlamydia in the United States (among all ages, races, ethnicities,
and male or female sex) was 475 per 100,000 and increased to 497.3 in 2016 (CDC,
2018). The rate of gonorrhea in the United States (among all ages, races, ethnicities, and
male or female sex) also rose from 123 per 100,000 in 2015 to 145.8 per 100,000 in 2016
(CDC, 2018). The CDC and the United States Department of Health and Human Services
(2016) recommended that all persons with a nonoccupational exposure who present a
significant risk of HIV acquisition should be evaluated by a healthcare professional and
offered nonoccupational postexposure prophylaxis (nPEP). Certain circumstances
increase the risk of contracting HIV or other STIs (CDC, 2018). One circumstance that
presents a significant risk of acquiring HIV/STIs is sexual assault (CDC, 2016;
Draughon, 2012: Ghosh, Rodriquez-Garcia, & Wira, 2013).
Sexual assault itself is a serious public health problem (CDC, 2018). Definitions
of rape and sexual assault and how data are collected vary widely. Prevalence statistics
are thus difficult to interpret and are believed to be underestimates. Breiding et al. (2014),
using data from the CDC’s National Intimate Partner and Sexual Violence Survey,
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estimated that there were 323,450 rapes and sexual assaults in 2011 or 1.2 per 100,000.
The self-survey participants were 18 years and older and had not reported to law
enforcement.
The United States Federal Bureau of Investigation (FBI) monitors rapes of all
ages that have been reported to the police. In 2011, 83,425 forcible rapes of females were
reported to law enforcement. The rate was 52.7 per 100,000. In December 2011, the FBI
changed their definition of rape to “penetration, no matter how slight, of the vagina or
anus with any body part or object, or oral penetration by a sex organ of another person,
without the consent of the victim.” The reference to females was removed. At present,
some data are reported according to the legacy definition and some according to the new
definition. The new definition has resulted in larger numbers. In 2015, rapes reported
using the legacy definition were 91,261 or 28.4 per 100,000 (FBI, 2015). Rapes
according to the new definition were 126,134 or 39.3 per 100,000 (FBI, 2015). In 2016,
there were 130,618 according to the new definition or 40.4 per 100,000 (FBI, 2016).
The Department of Justice National Crime Victims Survey is a self-report survey that
collects data on both rape and sexual assault in persons age 12 and older that have not
been reported to the police. In 2011, The Department of Justice National Crime Victims
Survey reported 243,800 rapes and sexual assaults or 0.9 per 100,000 (as cited in Truman
& Planty, 2012). In 2015, there were an estimated 431,840 events or 1.6 per 100,000
(Truman & Morgan, 2016). In 2016, there were 323,000 incidents or 1.2 per 100,000
(Morgan & Kena, 2017).
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Some sexual assault survivors seek care in hospital emergency departments
(EDs). A search of the WISQARS Nonfatal Injury Reports (2018) revealed that in 2011,
there were 78,521 victims of injuries (all ages, races, genders) related to sexual assault or
an age-adjusted rate of 26.3 per 100,000. In 2015, the number had increased to 80,590 or
26.6 per 100,000 (WISQARS, 2018). In 2016, there were 88,431 or a rate of 29.3 per
100,000 (WISQARS, 2018).
In the remainder of Section 1, I state the problem and the purpose of the study.
The research questions are then listed. Next, I review the theoretical foundation and the
nature of the study. The literature search strategy and literature review are included.
Finally, study definitions, assumptions, scope, delimitations, and significance are
discussed.
Problem Statement
Use of HIV screening/testing and prophylaxis has been found to be low in the
general ED population (Ende, Hein, Sottolano, & Agins, 2008; Merchant & Catanzaro,
2009; Rothman et al., 2011). In the general population, Blacks had a 70.3% incidence of
HIV testing in their lifetime of while Whites had only a 39.2% incidence (Lo, Runnels, &
Cheng, 2018). Less is known about the use of HIV/STI testing and prophylaxis among
sexual assault survivors who present to EDs. Amey and Bishai (2002) found a link
between age and underuse; however, this did not completely explain their conclusion that
many survivors are neither screened nor treated for HIV/STIs. Draughon et al. (2015)
observed increased compliance where a standardized protocol existed and when the
perpetrator was other than White race. In another study, researchers found that counseling
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and prophylaxis were more likely to be received by those younger than 25 years of age,
single, and employed among other factors, leading the authors to conclude that services
were not extended to all survivors (Dumont, Van, Kosa, & MacDonald, 2017). Patel,
Panchal, Piotrowski, and Patel (2008) and Patel, Roston, Tilmon, Stern, Roston, Patel,
and Keith (2013) found that comprehensive medical care management of sexual assault
was underused. Barriers to screening and treatment that have been identified to include
personal comfort of physician providers, physician/patient communication, and health
system obstacles (Amin, Buranosky, & Chang, 2016; Bakhru, Mallinger, & Fox, 2010).
There are also myriad barriers surrounding medication acceptance and compliance
(Dejelaj, Patterson, & Romero, 2017). Underuse and barriers may either contribute to or
be the result of healthcare disparities and inequities related to social determinants.
Purpose of the Study
Building on prior research, in this quantitative study, I attempt to identify and
describe other factors that influence whether sexual assault survivors are offered HIV/STI
screening/testing and prophylaxis (dependent variables) in hospital EDs when they
present for treatment. I specifically address the influence of the independent variables of
race and SES status in adult (≥ 18) sexual assault survivors because this is a meaningful
gap in the current research.
If healthcare disparities and inequities related to social determinants are
identified, they can be addressed and thus inspire positive social change. Among these
potential changes are improved prevention strategies, improved care of survivors of
sexual assault as it relates to HIV/STI screening/testing and prophylaxis, a decreased rate
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of HIV/STI transmission, a decreased economic burden of HIV and sexual assault
aftercare, and less social stigma. It could also be a step to addressing the challenges of
researching about sexual assault and increase the knowledge base in the field.
Individuals, families, the community, and society can benefit, consistent with the
socioecological theory upon which the study was based.
Original Research Questions and Hypotheses
The original main research questions were as follows:
Research Question (RQ)1: Is there a relationship between race (independent
variable) and HIV/STI testing (dependent variable) among sexual assault survivors?
Ho1: There is not a significant relationship between race and HIV/STI testing
among sexual assault survivors.
HA1: There is a significant relationship between race and HIV/STI testing among
sexual assault survivors.
RQ2: Is there a relationship between race (independent variable) and HIV/STI
prophylaxis (dependent variable) among sexual assault survivors?
Ho2: There is not a significant relationship between race and HIV/STI prophylaxis
among sexual assault survivors.
HA2: There is a significant relationship between race and HIV/STI prophylaxis
among sexual assault survivors.
RQ3: Is there a relationship between socioeconomic status (independent variable)
and HIV/STI testing (dependent variable) among sexual assault survivors?
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Ho3: There is not a significant relationship between socioeconomic status and
HIV/STI testing among sexual assault survivors.
HA3: There is a significant relationship between neighborhood socioeconomic
status and HIV/STI testing among sexual assault survivors.
RQ4: Is there a relationship between socioeconomic status (independent variable)
and HIV/STI prophylaxis received (dependent variable) among sexual assault survivors?
Ho4: There is not a significant relationship between socioeconomic status and
HIV/STI prophylaxis received among sexual assault survivors.
HA4: There is a significant relationship between socioeconomic status and
HIV/STI among sexual assault survivors.
Final Research Questions and Hypotheses
The original research questions as stated above were changed in wording to better
reflect the answers sought. Seven additional research questions were developed to reflect
the identification and addition of possible significant variables during the course of the
research. These changes were necessary to be flexible and make the best use of the
sample size and characteristics. The lack of availability of some data also contributed to
the need to alter the research questions and hypotheses slightly. The final research
questions were as follows:
RQ1: Is there a statistically significant difference between races (independent
variable) and receipt of HIV tests (dependent variable) among sexual assault survivors in
the ED?

7
H01: There is not a statistically significant difference between race and HIV test
received among sexual assault survivors in the ED.
HA1: There is a statistically significant difference between races and HIV test
received among sexual assault survivors in the ED.
RQ2: Is there a statistically significant difference between races (independent
variable) and receipt of urine tests and/or pelvic exams (dependent variables) to diagnose
sexually transmitted infections among sexual assault survivors in the ED?
H02: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
HA2: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
RQ3: Is there a statistically significant difference between races (independent
variable) and receipt of HIV/STI medication treatment or prophylaxis (dependent
variable) among sexual assault survivors in the ED?
H03: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
HA3: There is a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.

8
RQ4: Is there a statistically significant difference between socioeconomic status
(independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED?
H04: There is not a statistically significant difference between socioeconomic
status and HIV test received among sexual assault survivors in the ED.
HA4: There is a statistically significant difference between socioeconomic status
and HIV test received among sexual assault survivors in the ED.
RQ5: Is there a statistically significant difference between socioeconomic status
(independent variable) and receipt of urine tests and/or pelvic exams to diagnose sexually
transmitted infections (dependent variable) among sexual assault survivors in the ED?
H05: There is not a statistically significant difference between socioeconomic
status and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted
infections received among sexual assault survivors in the ED.
HA5: There is a statistically significant difference between socioeconomic status
and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted infections
received among sexual assault survivors in the ED.
RQ6: Is there a statistically significant difference between socioeconomic status
(independent variable) and HIV/STI medication treatment or prophylaxis received
(dependent variable) among sexual assault survivors in the ED?
H06: There is not a statistically significant difference between socioeconomic
status and HIV/STI medication treatment or prophylaxis received among sexual assault
survivors in the ED.
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HA6: There is a statistically significant difference between socioeconomic status
and between socioeconomic status and HIV/STI medication treatment or prophylaxis
received among sexual assault survivors in the ED.
RQ7: Is there a statistically significant difference between geographic region
(independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED?
H07: There is not a statistically significant difference between geographic region
and HIV/STI medication treatment or prophylaxis received among sexual assault
survivors in the ED.
HA7: There is a statistically significant difference between geographic region and
between socioeconomic status and HIV/STI medication treatment or prophylaxis
received among sexual assault survivors in the ED.
RQ8: Is there a statistically significant difference between geographic region
(independent variable) and receipt of urinalysis or pelvic exam (dependent variable)
among sexual assault survivors in the ED?
H08: There is not a statistically significant difference between geographic region
and HIV tests received among sexual assault survivors in the ED.
HA8: There is a statistically significant difference between geographic region and
urinalysis or pelvic exam received among sexual assault survivors in the ED.
RQ9: Is there a statistically significant difference between geographic region
(independent variable) and receipt of appropriate medications (dependent variable)
among sexual assault survivors in the ED?
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H09: There is not a statistically significant difference between geographic region
and appropriate medications received among sexual assault survivors in the ED.
HA9: There is a statistically significant difference between geographic region and
appropriate medication received among sexual assault survivors in the ED.
RQ10: Is there a statistically significant difference between age (independent
variable) and receipt of urinalysis or pelvic exam (dependent variable) among sexual
assault survivors in the ED?
H010: There is not a statistically significant difference between age and urinalysis
or pelvic exam received among sexual assault survivors in the ED.
HA10: There is a statistically significant difference between age and urinalysis or
pelvic exam received among sexual assault survivors in the ED.
RQ11: Is there a statistically significant difference between age (independent
variable) and appropriate medication received (dependent variable) among sexual assault
survivors in the ED?
H011: There is not a statistically significant difference between age and
appropriate medications received among sexual assault survivors in the ED.
HA11: There is a statistically significant difference between age and appropriate
medications received among sexual assault survivors in the ED.
Theoretical Foundation for the Study
Ecological theories are sets of related concepts that provide a systematic way of
looking at relationships among variables (Glanz, Rimer, & Viswanath, 2015). Ecological
models, which are influenced by multiple theories, attempt to explain and predict specific
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problems in specific settings (Glanz et al., 2015). They are useful for conceptualizing the
many different levels of influences on health behavior (Glanz et al., 2015). The main
theory underlying ecologic models is that behavior has multiple levels of influence and
that all levels of influence are important (Glanz et al., 2015). A second principle is that
behavior settings restrict the range of a person’s behavior, thus influencing it under
certain circumstances (Glanz et al., 2015). Further, influences interact across the levels
(Glanz et al., 2015). Another important principle is that interventions are more powerful
when they focus on a specific behavior and occur on multiple levels (Glanz et al., 2015).
The ecologic model was appropriate for this study because I aimed to identify and
describe the specific problems or behaviors that influence whether sexual assault
survivors are offered HIV/STI screening/testing and prophylaxis in the specific setting of
the hospital EDs. The CDC (2018b) uses this model for their violence prevention model.
There are four levels: individual, relationship, community, and societal (CDC, 2018).
In this study, the sexual assault survivor or patient is on the individual level.
Factors to be identified include race and SES status. To be identified are any other factors
that increase the likelihood that HIV/STI prophylaxis will or will not be offered and/or
accepted and complied with. On the relationship level are the individual’s family and/or
support systems and social capitol, which may or may not influence their ability to accept
and comply with treatment. The health care provider develops a relationship with the
sexual assault survivor as well; however, their setting of the hospital ED makes it also on
the community level. Policy changes to intervene on this level may affect the lived
experience of the sexual assault survivor and the practice of the health care provider. In
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this study, I touch the societal level by exploring whether social norms about race and
SES support or hinder care and whether there is inequality among groups.
Ecologic models have been used in public health for decades. Results of this study
could result in identification of areas to intervene in the tradition of ecologic models of
health behavior, health promotion, and multilevel structural change (see Glanz et al.,
2015). A strength of the ecologic model is the study of multilevel influences (Glanz et al.,
2015). Policy or environment changes can help sustain behavior change on the individual
and community levels (Glanz et al., 2015).
A weakness of ecologic models is that they can be more demanding to work with
and difficult to test (Glanz et al., 2015). They can also be costly and impractical when
interventions are needed on multiple levels (Glanz et al., 2015). Overall, however,
ecologic models are simple in that they recognize that individuals and communities
cannot sustain healthy behaviors without policy and environmental support.
Nature of the Study
The study was a quantitative cross-sectional survey design using secondary data
from the National Hospital Ambulatory Medical Care Survey (NHAMCS). The survey
design enabled me to rapidly make inferences about the population of sexual assault
survivors. Further, it was pragmatic and economical in form. The key study variables
were whether the influence of the independent variables of race and SES had a
relationship to whether adult (≥ 18) sexual assault survivors are offered HIV/STI
screening/testing and prophylaxis (dependent variables) in hospital EDs in the United
States.
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Descriptive statistics were computed using SPSS. Frequencies were run on all
variables. As part of logistic regression, Chi-square analysis of the measurement
variables was done to test their significance.
Literature Search Strategy
Walden University and Saint Luke’s Health System Libraries were used.
Databases and search engines used included EBSCO, PubMed, CINAHL, MEDLINE,
ProQuest, OVID, Open Athens, and Google. Key search terms and combinations of
search terms included sexual assault, sexual abuse, rape, HIV, STI, gonorrhea,
chlamydia, forensic nursing, post exposure prophylaxis, nonoccupational post exposure
prophylaxis, emergency department service use, sexually transmitted disease, emergency
department, trichomoniasis, and bacterial vaginosis. The scope of literature review was
primarily the last 16 years.
Literature Review Related to Key Variables and/or Concepts
In the following review, I focus on research that addressed the dependent
variable: HIV/STI screening/testing, treatment, and prophylaxis in sexual assault
survivors in EDs in the United States. Some were chosen because they used the
NHAMCS database, which was the source of data for the study. Some were chosen
because they used similar methodology and/or analytical techniques as the I did. Some
were chosen as models for the study. In the following paragraphs, I describe in
chronological order how the problem has been approached thus far and the strengths and
weaknesses of previous studies. Through review and synthesis of these studies, the
research question and the selection of the variables in the study are justified.
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Amey and Bishai (2002) set the precedent for studying the quality of services
extended to victims of sexual assault. Although their study was limited to women, it
provided a foundation and rationale for studying the experience of those who present to
EDs after sexual assault (Amey & Bishai, 2002). The variables of HIV/STI screening and
treatment, race, and payor status were among those studied and provided a baseline for
comparison by this study. The study also helps to establish that numbers of patients
presenting with sexual assault are consistent with those reported to law enforcement, thus
informing future studies and helping to identify the prevalence. The NHAMCS is the
database from which Amey and Bishai derived the study sample, as did I in this study.
The independent variable of race was studied, and the study found that Black women
received more services. Limitations of the study and using the national database included
possible coding errors, being limited to information abstracted, difficulty in capturing
transfer patients, a lower sample size, and the inability to address psychosocial aspects of
care and follow up (Amey & Bishai, 2002). Overall, Amey and Bishai provided a
template for this study.
In 2008, three studies addressed the provision of services to sexual assault
patients in EDs on the state level. Ende et al. (2008) studied one aspect of care: initiation
of nPEP. Merchant, Phillips, DeLong, Mayer, and Becker (2008) studied disparities in
the provision of HIV/STI testing and prophylaxis for women sexually assaulted and
presenting in Rhode Island EDs. In Illinois, the comprehensive medical care of sexual
assault victims in EDs including HIV/STI management was studied by Patel, Panchal,
Piotrowski, and Patel (2008). All concluded that guidelines for care of sexual assault
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victims were under implemented and services were underprovided to varying degrees.
Merchant et al. used a logistic regression model for analysis, which I also used in this
study. These state studies may not be generalizable to other states or the national level.
Bakhru et al. (2010) also informed, supported, and justified my study by
identifying potential barriers to postexposure prophylaxis for sexual assault victims in
EDs, specifically treatments and attitudes of ED physicians. Rothman et al. (2011) also
informed and supported this study by finding in their national web-based survey that
most ED programs did not have systematic HIV testing programs for anyone. In 2018,
Niferatos et al. reinforced these findings by their study of ED patients who received
HIV/STI laboratory testing, including sexual assault patients. In those cases, a lack of
documentation of a complete sexual history was identified as a barrier to care and
associated with suboptimal testing and treatment (Niferatos et al., 2018).
The hypothesis of increased risk of HIV transmission among sexual assault
victims (Draughon, 2012) is a central concept underpinning the research problem that
supported and informed this research project. Draughon and Sheridan (2012) studied part
of the dependent variable, nPEP evaluation in sexual assault survivors, and found there to
be a need for further research to better understand the process. Draughon, Anderson,
Hansen, and Sheridan (2014) reaffirmed that finding in a survey of Sexual Assault Nurse
Examiner programs and Forensic Nurse Examiners programs studying nPep. These
justified the need for this study, which builds on and adds to this body of research. In a
similar study, in 2015, Draughon et al. looked at nurses offering nPEP post sexual
assault. They also used similar methodology and analysis techniques as I did. Jaureguy,
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Chariot, Vessieres, and Picard (2016) studied an adult and adolescent sexual assault
population outside Paris, France. They found that Chlamydia trachomatis was present in
15% of patients and Neisseria gonorrhea was present in 5% (Jaureguy et al., 2016). Three
percent of patients had both Chlamydia trachomatis and Neisseria gonorrhea (Juareguy
et al., 2016). The only study not affirming that sexual assault was associated with higher
rates of HIV and STI was done by Van Rooijen, Schim van der Loeff, van Kempen, and
DeVries (2018). The researchers found that female sexual assault survivors had a positive
STI rate of 11.2% while nonvictims had a rate of 11.6% (Van Rooijen et al., 2018).
Survivors did not have increased odds of getting a STI either (Van Rooijen et al., 2018).
Very little has been studied in relation to male victims of sexual assault. Du Mont,
Macdonald, White, and Turner (2013) studied the use of services in male clients in
Canada and found acceptance, including HIV/STI testing. They identified a need for
further research, which helped justify my study that addressed both the male and female
gender. The same year, a study of females receiving comprehensive medical care
management for sexual assault (which includes HIV/STI screening and treatment) found
that less than 1/5th of U.S. hospitals complied (Patel et al., 2013). In 2014, Krause et al.
examined then current practices in EDs, finding that 100% of eligible candidates were
offered HIV/STI testing in their sample of 138. Malverni, Libois, Gennotte, LaMorté, and
Mols (2016) determined that only 60% of emergency physicians in their Belgian study
complied with prescribing guidelines. Of those prescriptions, nearly all were appropriate,
but compliance with treatment was poor in sexual assault survivors (Malverni et al.,
2016). Tapesana et al. (2017) found that suboptimal care including HIV/STI prophylaxis,
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testing, and treatment was given to sexual assault patients over a 2-year period. Muriuki,
Kimani, Machuki, Kiarie, and Roxby (2017), in a Kenyan study that included sexual
assault survivors of all ages, found PEP given in only 54%, with 34% completing
treatment. Use of violence services was compared between intimate partners and other
sexual assault survivors by DuMont, Woldeyoyohannes, Macdonald, Kosa, and Turner
(2017), including STI prophylaxis and HIV PEP counseling. The authors found that those
involved in intimate partner violence were less likely to partake in services DuMont et
al., 2017). DuMont et al. also had a similar focus and methods as this study. DuMont et
al. (2017) also looked specifically at HIV PEP counseling just in the intimate partner
violence survivor. Limitations included differences in data collection, self-report bias,
limited generalizability, and failure to include a multivariate analysis (DuMont et al.,
2017). Monuteaux, Fleegler, and Lee (2017) informed, supported, and justified my study
as well by helping to establish the scope of the problem and quantify the cost. Monuteaux
et al., 2017 used the National Hospital Ambulatory Medical Care Survey-ED from 2000
to 2010, the limitations of which were previously noted. The analysis methods of
Monuteaux et al. were similar to my study methods and analysis techniques, including
regression logistics. Scanell, Kim, and Guthrie (2018) looked at the acceptance of HIV
postexposure prophylaxis in the sexual assault population. As did almost every other
study, Scanell et al. showed deficiency in health care delivery of nPep in EDs.
In summary, the above synthesis along with information from other sources
served as a foundation for further research into the provision of HIV/STI screening,
treatment, and prophylaxis among sexual assault survivors. The previous studies that
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used the same dependent variable as I did also provide a foundation and tradition. Many
of the studies used the same database, methodology, and analytic techniques as me, yet
new knowledge can be gained by studying this variable in relation to age and SES .
Study Definitions and Assumptions
The dependent variable was HIV/STI screening, testing, treatment, or
prophylaxis. HIV/STI screening is recommended for all victims of sexual assault (CDC,
2016). Testing may not be desired or efficacious in all circumstances and thus should be
considered on a case by case basis (CDC, 2016). For example, a sexual assault patient is
unlikely to test positive for an STI on the same day as the assault. The patient may opt to
accept treatment without testing based on risk factors. Further, positive results might
indicate a preexisting STI, which defense attorneys may use to discredit the victim if their
case is adjudicated (CDC, 2016). Postexposure prophylaxis for HIV requires some testing
and should also be decided considering risk factors and the patient’s ability to comply
with the regimen (CDC, 2016).
The independent variables were race and SES. Race as a biological concept has
no clear or effective definition for humans, while in practice, race is socially defined.
Races were defined according to Directive # 15 of the Office of Management and Budget
Race and Ethnic Standards for Federal Statistics and Administrative Reporting (1977) as
follows:
White is a person having origins in any of the original peoples of Europe, North
Africa, or the Middle East, Black/African American is a person having origins in
any of the black racial groups of Africa, Asian and Hawaiian/Other Pacific
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Islander is defined as a person having origins in any of the original peoples of the
Far East, Southeast Asia, the Indian subcontinent, or the Pacific Islands,
American Indian or Alaska Native is a person having origins in any of the original
peoples of North America, and who maintains cultural identification through
tribal affiliation or community recognition (p. 1).
Race was coded as follows: 1 = White, 2 = Black/African American, 3 = Asian, 4
= Native Hawaiian/Other Pacific Islander, 5 = American Indian/Alaska Native, 6 = More
than one race reported, and -9 = race left blank.
Socioeconomic status (SES) will be assumed from expected source of payment.
Private Pay/insurance, Medicare, and Workman’s Compensation will be considered high
SES. Medicaid, Self-pay, and No Charge will be considered low socioeconomic status.
Blank, Unknown, and Other were excluded from the final analysis by SPSS. These
assumptions are necessary because the database does not specifically record income.
Scope and Delimitations
As the proposed study is not experimental, threats to internal and external validity
are confined to selection. Participants will be selected because they have been sexually
assaulted, and this may predispose them to certain outcomes (Creswell, 2009). For
example, some people who are sexually assaulted belong to high risk groups (e.g. IV
drug user) which makes them higher risk for HIV/STIs.
The proposed study will use data from adults (defined as equal to or greater than
18 years of age). This is because HIV/STI protocols vary significantly for children and
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adolescents (CDC, 2016). The study participants will be male and female sex because the
NHAMCS database collects it that way (NHAMCS, 2015). Persons who present to the
ED greater than 72 hours after the assault will be excluded because HIV protocols require
presentation within 72 hours for prophylaxis (CDC, 2016). These measures will help to
support construct validity. Because the study outcomes are meant to benefit a specific
population, generalizability is not a primary concern.
Significance, Summary, and Conclusions
A potential contribution of the proposed study would be to test the findings of
Amey and Bishai (2002) that Black/African-American women received more HIV/STI
services than did white women. The proposed study would also expand and further define
who is receiving services by including Asian, Native Hawaiian/Other Pacific Islander,
American Indian/Alaska Native, and more than one race reported. The study also may
point to opportunities for improvement for service providers, particularly if patient
acceptance is influenced by provider type and approach. The presence or absence of
standardized protocols and degree of implementation or compliance may also affect
patient acceptance.
The over-arching theme of the literature, and what is well known, is that victims
of sexual assault are not receiving all the services that they are eligible for in U.S. EDs. If
any insight can be made into the demographics or behavior of the population or the
caregivers a potential for positive social change exists consistent with the scope of the
study. This study would fill gaps in the current literature and extend knowledge in the
field.
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Section 2: Research Design and Data Collection
In this study, I attempted to identify and describe factors that may have influenced
whether sexual assault survivors were offered HIV/STI screening/testing and prophylaxis
(dependent variables) in hospital EDs when they presented for treatment. Independent
variables of interest were race, socioeconomic status, geographic region, and age. In this
chapter, I discuss the research design and rationale for the study. I also describe the
methodology, including population, sampling and sampling procedures,
operationalization of the variables, and the data analysis
Research Design and Rationale
A quantitative approach was appropriate because I used numeric data to
generalize about the characteristics of sexual assault survivors seen in United States EDs
from 2010 to 2016 so that inferences could be made about their needs (see Aschengrau &
Seage, 2014; Creswell, 2009). The cross-sectional design was appropriate because
secondary data were analyzed. Generalizability, speed, and low cost are advantages of
secondary data analysis (Aschengrau & Seage, 2014). The data were collected by record
review. Logistic regression was appropriately used because I was able to place
individuals into categories, and the dependent variables were binary (yes/no) for HIV/STI
screening, testing, and prophylaxis.
Methodology Population
The original study population was participants in the National Hospital
Ambulatory Medical Care Surveys 2010 to 2016. The total number of patient records
reviewed was 159. Cases were identified as sexual assault survivors by, reason for visit
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codes 58300 (adult sexual abuse) and 58301 (child sexual abuse), and/or diagnosis code
V71.5 (observation after alleged rape or sexual assault) and/or cause or E code 9601.0
(rape). Originally, patients under 18 or who presented greater than 72 hours after the
assault were to be excluded, but they were ultimately included in order to obtain a larger
sample size. Because the data were secondary data, there were no means to identify
individuals in the population. It was necessary to arrange the data so that they were easier
to work with. All data manipulation and statistical analyses were done using SPSS. The
target population size was expected to be small because of well-known issues with
reporting and documentation of sexual violence, as previously described. Potential for
identifying patients exists through cross checking records of patients who receive
HIV/STI screening/testing and treatment/prophylaxis medications.
Sampling Procedures
The Raosoft® sample size calculator was used to determine an a priori adequate
sample size with a 95% confidence level (CL). One-hundred fifty-nine records that met
the identification criteria were identified. A response distribution was estimated at 50%
because there was no clear expectation of what the results would be. Therefore, 113
records would have been required for adequate power. All 159 records were ultimately
included. If other factors had excluded records, the size could have been recalculated or,
if necessary, a compromise analysis could have been done if an ideal sample size could
not have been assembled. Surveying a representative random sample was the preferred
method of data collection for this study because of the ease and rapidity of collection and
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lower/no cost (see Creswell, 2009). Inclusion criteria was ICD 9 codes 58300, 58301,
V71.5, or 9601 as noted above.
NHAMCS (2015) estimates are considered reliable when each is based on 30
unweighted records and the weighted data had a relative standard of error of less than
30%. Unweighted records are only used for determining the sample number. Weighted
data were used to make national estimates. The secondary data set that I used was the
NHAMCS.
The NHAMCS is an annual, national probability sample of ambulatory visits
made to nonfederal, general, and short-stay hospitals in the U.S. conducted by the
Centers for Disease Control and Prevention, National Center for Health
Statistics…. hospitals are inducted into the NHAMCS by field representatives of
the U.S. Census Bureau. Hospital staff or Census Bureau field representatives
complete a patient record form for each sampled visit based on information
obtained from the medical record. (NHAMCS, 2018, p. 1)
In this analysis, I focused solely on ED visits. NHAMCS is a public access
database. Permission was not required for the data that were used for this study.
Operationalization
There were ultimately four, numeric type independent variables. The independent
variables were race, socioeconomic status, geographic region, and age. The dependent
variables were HIV/STI screening, testing, treatment, or prophylaxis. All variables were
nominal. Numbers are used to classify objects or put them into categories and have no
quantitative meaning (Polit & Beck, 2010). For example, no services provided was coded
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as 0, HIV/STI screening provided was coded as 1 and so on. Percentages indicated the
number of patients receiving services and what services those were.
Data Analysis Plan
Sample visit weight was used to analyze data at all stages of the sample design
(see NHAMCS, 2015). The sampling weights were adjusted for survey nonresponse
within a set of parameters, which yielded an unbiased national estimate of ED visits,
percentages, and characteristics (see NHAMCS, 2015). SPSS was used for analysis in
this study. Missing data were cleaned and controlled for as appropriate. The final
research questions as noted in Section 1 were:
RQ1: Is there a statistically significant difference between races (independent
variable) and receipt of HIV tests (dependent variable) among sexual assault survivors in
the ED?
H01: There is not a statistically significant difference between race and HIV test
received among sexual assault survivors in the ED.
HA1: There is a statistically significant difference between races and HIV test
received among sexual assault survivors in the ED.
RQ2: Is there a statistically significant difference between races (independent
variable) and receipt of urine tests and/or pelvic exams (dependent variables) to diagnose
sexually transmitted infections among sexual assault survivors in the ED?
H02: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
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HA2: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
RQ3: Is there a statistically significant difference between races (independent
variable) and receipt of HIV/STI medication treatment or prophylaxis (dependent
variable) among sexual assault survivors in the ED?
H03: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
HA3: There is a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
RQ4: Is there a statistically significant difference between socioeconomic status
(independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED?
H04: There is not a statistically significant difference between socioeconomic
status and HIV test received among sexual assault survivors in the ED.
HA4: There is a statistically significant difference between socioeconomic status
and HIV test received among sexual assault survivors in the ED.
RQ5: Is there a statistically significant difference between socioeconomic status
(independent variable) and receipt of urine tests and/or pelvic exams to diagnose sexually
transmitted infections (dependent variable) among sexual assault survivors in the ED?
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H05: There is not a statistically significant difference between socioeconomic
status and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted
infections received among sexual assault survivors in the ED.
HA5: There is a statistically significant difference between socioeconomic status
and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted infections
received among sexual assault survivors in the ED.
RQ6: Is there a statistically significant difference between socioeconomic status
(independent variable) and HIV/STI medication treatment or prophylaxis received
(dependent variable) among sexual assault survivors in the ED?
H06: There is not a statistically significant difference between socioeconomic
status and HIV/STI medication treatment or prophylaxis received among sexual assault
survivors in the ED.
HA6: There is a statistically significant difference between socioeconomic status
and between socioeconomic status and HIV/STI medication treatment or prophylaxis
received among sexual assault survivors in the ED.
RQ7: Is there a statistically significant difference between geographic region
(independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED?
H07: There is not a statistically significant difference between geographic region
and HIV/STI medication treatment or prophylaxis received among sexual assault
survivors in the ED.
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HA7: There is a statistically significant difference between geographic region and
between socioeconomic status and HIV/STI medication treatment or prophylaxis
received among sexual assault survivors in the ED.
RQ8: Is there a statistically significant difference between geographic region
(independent variable) and receipt of urinalysis or pelvic exam (dependent variable)
among sexual assault survivors in the ED?
H08: There is not a statistically significant difference between geographic region
and HIV tests received among sexual assault survivors in the ED.
HA8: There is a statistically significant difference between geographic region and
urinalysis or pelvic exam received among sexual assault survivors in the ED.
RQ9: Is there a statistically significant difference between geographic region
(independent variable) and receipt of appropriate medications (dependent variable)
among sexual assault survivors in the ED?
H09: There is not a statistically significant difference between geographic region
and appropriate medications received among sexual assault survivors in the ED.
HA9: There is a statistically significant difference between geographic region and
appropriate medication received among sexual assault survivors in the ED.
RQ10: Is there a statistically significant difference between age (independent
variable) and receipt of urinalysis or pelvic exam (dependent variable) among sexual
assault survivors in the ED?
H010: There is not a statistically significant difference between age and urinalysis
or pelvic exam received among sexual assault survivors in the ED.
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HA10: There is a statistically significant difference between age and urinalysis or
pelvic exam received among sexual assault survivors in the ED.
RQ11: Is there a statistically significant difference between age (independent
variable) and appropriate medication received (dependent variable) among sexual assault
survivors in the ED?
H011: There is not a statistically significant difference between age and
appropriate medications received among sexual assault survivors in the ED.
HA11: There is a statistically significant difference between age and appropriate
medications received among sexual assault survivors in the ED.
Descriptive statistics were completed. Frequencies were run on all variables. Chisquare was done as part of binomial logistic regression. Binomial logistic regression was
done to predict outcomes based on characteristics of the population served. A 95% CL
was desired as stated under sampling.
Threats to Validity
The NHAMCS results have sampling and nonsampling errors. Errors included
reporting and processing errors and nonresponse and incomplete response bias
(NHAMCS, 2015). In addition, race data were missing from some records (NHAMCS,
2015). As stated previously, this study was not experimental; therefore, threats to internal
and external validity were confined to selection. No threats to construct or statistical
validity were identified.
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Ethical Procedures
Access to the portion of the NHAMCS being used for this study was open to the
public for downloading in various formats. Additional data were available from the
Research Data Center at the National Center for Health Statistics, which requires an
approval process for access. NHAMCS falls under Title 42, United States Code, Section
242K, which allows data collection for health research. All information is only used for
statistical purposes and is anonymous and confidential (NHAMCS, 2018). Institutional
review board procedures for this study were followed as required. The IRB approval
number was 08-28-19-0251965. There were no potential ethical concerns related to
human participants and no other ethical issues were identified.
Summary
In this study, I attempted to identify and describe factors that may have influenced
whether sexual assault survivors were offered HIV/STI screening/testing and prophylaxis
in hospital EDs when they presented for treatment. A quantitative approach and crosssectional design were appropriate. The original study population was the participants in
the NHAMCS 2010-2016. Sampling procedures were followed. Variables were identified
and defined. A data analysis plan was developed and implemented. Threats to validity
and ethical issues were considered.
Section 3: Presentation of the Results and Findings
The purpose of this research was to identify and describe factors that influence
whether sexual assault survivors were offered HIV/STI screening or testing, and/or
treatment/prophylaxis (dependent variables) in hospital EDs when they presented for
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care. Specifically, I looked at the influence of race, socioeconomic status, geographic
region, and age (independent variables). Data from 2010 through 2016 was used. The
sample size was 159. The Raosoft® sample size calculator was used to determine that a
sample size of at least 113 was required for adequate power.
Sexual assault survivors were identified by reason for visit codes 58300 (adult
sexual abuse) and 53001 (child sexual abuse) and/or diagnosis code V71.5 (observation
after alleged rape or sexual assault) and/or cause E code 9601 (rape). Definitions of race
remained the same; however, only Black and White races were used in the final sample
because there was not a large enough number of the other races to perform regression.
Socioeconomic definitions and assumptions were the same.
Participants were divided into two groups. People with private insurance,
Medicare, or Workman’s Compensation were assumed to have high income. People with
Medicaid, self-pay, and no charge were assumed to have low income. Records that had
methods of payment as other, blank, and unknown were excluded from the
socioeconomic questions.
The lack of availability of certain data contributed to the need to alter the research
questions and hypotheses slightly from the original as noted in Section 1. For example,
there were data available for HIV screening/testing specifically, but not for other STIs. I
assumed that screening/testing for STIs was done if any urine was tested or pelvic exam
done. I also assumed that treatment/prophylaxis was received by patients who received
antibiotics, anti-HIV drugs, Plan B emergency contraception, or vaccines that are
normally part of a sexual assault treatment protocol.
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The main research questions and hypotheses were:
RQ1: Is there a statistically significant difference between races (independent
variable) and receipt of HIV tests (dependent variable) among sexual assault survivors in
the ED?
H01: There is not a statistically significant difference between race and HIV test
received among sexual assault survivors in the ED.
HA1: There is a statistically significant difference between races and HIV test
received among sexual assault survivors in the ED.
RQ2: Is there a statistically significant difference between races (independent
variable) and receipt of urine tests and/or pelvic exams (dependent variables) to diagnose
sexually transmitted infections among sexual assault survivors in the ED?
H02: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
HA2: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
RQ3: Is there a statistically significant difference between races (independent
variable) and receipt of HIV/STI medication treatment or prophylaxis (dependent
variable) among sexual assault survivors in the ED?
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H03: There is not a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
HA3: There is a statistically significant difference between races and receipt of
urine tests and/or pelvic exams to diagnose sexually transmitted infections among sexual
assault survivors in the ED.
RQ4: Is there a statistically significant difference between socioeconomic status
(independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED?
H04: There is not a statistically significant difference between socioeconomic
status and HIV test received among sexual assault survivors in the ED.
HA4: There is a statistically significant difference between socioeconomic status
and HIV test received among sexual assault survivors in the ED.
RQ5: Is there a statistically significant difference between socioeconomic status
(independent variable) and receipt of urine tests and/or pelvic exams to diagnose sexually
transmitted infections (dependent variable) among sexual assault survivors in the ED?
H05: There is not a statistically significant difference between socioeconomic
status and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted
infections received among sexual assault survivors in the ED.
HA5: There is a statistically significant difference between socioeconomic status
and receipt of urine tests and/or pelvic exams to diagnose sexually transmitted infections
received among sexual assault survivors in the ED.
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RQ6: Is there a statistically significant difference between socioeconomic status
(independent variable) and HIV/STI medication treatment or prophylaxis received
(dependent variable) among sexual assault survivors in the ED?
H06: There is not a statistically significant difference between socioeconomic
status and HIV/STI medication treatment or prophylaxis received among sexual assault
survivors in the ED.
HA6: There is a statistically significant difference between socioeconomic status
and between socioeconomic status and HIV/STI medication treatment or prophylaxis
received among sexual assault survivors in the ED.
RQ7: Is there a statistically significant difference between geographic region
(independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED?
H07: There is not a statistically significant difference between geographic region
and HIV/STI medication treatment or prophylaxis received among sexual assault
survivors in the ED.
HA7: There is a statistically significant difference between geographic region and
between socioeconomic status and HIV/STI medication treatment or prophylaxis
received among sexual assault survivors in the ED.
RQ8: Is there a statistically significant difference between geographic region
(independent variable) and receipt of urinalysis or pelvic exam (dependent variable)
among sexual assault survivors in the ED?
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H08: There is not a statistically significant difference between geographic region
and HIV tests received among sexual assault survivors in the ED.
HA8: There is a statistically significant difference between geographic region and
urinalysis or pelvic exam received among sexual assault survivors in the ED.
RQ9: Is there a statistically significant difference between geographic region
(independent variable) and receipt of appropriate medications (dependent variable)
among sexual assault survivors in the ED?
H09: There is not a statistically significant difference between geographic region
and appropriate medications received among sexual assault survivors in the ED.
HA9: There is a statistically significant difference between geographic region and
appropriate medication received among sexual assault survivors in the ED.
RQ10: Is there a statistically significant difference between age (independent
variable) and receipt of urinalysis or pelvic exam (dependent variable) among sexual
assault survivors in the ED?
H010: There is not a statistically significant difference between age and urinalysis
or pelvic exam received among sexual assault survivors in the ED.
HA10: There is a statistically significant difference between age and urinalysis or
pelvic exam received among sexual assault survivors in the ED.
RQ11: Is there a statistically significant difference between age (independent
variable) and appropriate medication received (dependent variable) among sexual assault
survivors in the ED?
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H011: There is not a statistically significant difference between age and
appropriate medications received among sexual assault survivors in the ED.
HA11: There is a statistically significant difference between age and appropriate
medications received among sexual assault survivors in the ED.
In the rest of this section, I outline the time frame for data collection. I also
describe recruitment and response rates of the secondary data set. Baseline descriptive
and demographic characteristics of the sample, as well as how representative of the
population the sample is, are reported. I also report basic statistics and analyses, including
tables.
Data Collection of Secondary Data Set
This study was a secondary analysis of data collected in the NHAMCS years 2010
to 2016. The annual survey has been conducted since 1992. These data focus on visits to
hospital EDs. Information is obtained from the patient’s medical record. The sample
design was composed of multiple stages that include 112 geographic primary sampling
units, about 480 hospitals within the sampling units, and patient visits to the EDs
(NHAMCS, 2016). The survey items collected included demographics, reasons for visits,
cause of injury, diagnosis, diagnostic tests ordered, and medications given or prescribed.
Table 1 lists the approximate percent of sampled hospitals that participated each
year and provided complete information and a total unweighted response rate for each of
the years used in this study.
Table 1
Percentage Participation and Unweighted Response Rate
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Year

Conducted

% participation

Unweighted
response rate

2010
2011
2012
2013
2014
2015
2016

12-28-09 to 12-26-10
12-27-10 to 12-25-11
12-26-11 to 12-28-12
12-24-12 to 12-22-13
12-23-13 to 12-21-14
12-29-14 to 12-27-15
12-28-15 to 12-25-16

92%
87%
76.3%
80.8%
75.5%
70.8%
73.4%

87.5%
80.4%
63.6%
65.8%
60.6%
55.1%
51.7%

# of
participants
current study
30
16
28
22
26
21
16

NHAMCS is approved every year by the Ethics Review Board and the
requirements for informed consent of patients and patient authorization for release of
medical records are waived (NHAMCS, 2016). Data processing is performed by SRA
International, Inc., Durham, NC. Error rates usually range between 0.3% and 0.9%
(NHAMCS, 2016, p.1). NHAMCS data were analyzed using the sampled visit weight
which were adjusted for survey nonresponse resulting in a nonbiased national estimate of
ED visit characteristics (NHAMCS, 2016).
Results and Findings
In Table 2, the sample age range and mean are reported. Table 2
Sample Age Range and Mean
Sample n
159

Range
1-60

Mean
23.47

In Table 3 baseline descriptive and demographic characteristics of the sample are
reported.

Table 3
Full Sample Baseline Descriptive and Demographic Characteristics
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Baseline characteristic
Sex
Female
Male
Total
Race
Blank*
White only
Black/ African American only
More than one race reported
Recoded expected primary source of payment
Unknown*
Private insurance
Medicare
Medicaid
Worker’s compensation
Self-Pay
No charge
Other*
Geographic region
Northeast
Midwest
South
West

n

%

133
26
159

83.6
16.4
100%

35
87
35
2

22
54.7
22
1.3

23
38
7
61
2
18
7
3

14.5
23.9
4.4
38.4
1.3
11.3
4
2

37
37
57
28

17.6
18.9
25.8
13.8

*Excluded from final analysis using SPSS

In Table 4 the final sample characteristics and numbers are described. Table 4
Final Sample Racial, Socioeconomic, Geographic Region, and Age Categories
Baseline characteristic
n
Race*
White only
87
Black/African American only
35
Total
122
Socioeconomic status (SES)**
Low SES
79
High SES
47
Total
126
Geographic region
Northeast
37
Midwest
37
South
57
West
28
Total
159
Age groups
Group 0-10
23

%
71.3
28.7
100
62
38
100
23.3
23.3
35.8
17.6
100
14.5
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Group 11-20
Group 21-30
Group 31-40
Group 41-50
Group 51-60

51
41
28
9
7

32.1
25.8
17.6
5.7
4.4

Total
159
100
*There was not a large enough sample of the other races to perform regression. See page
28. ** Recoded Expected Primary Sources of Payment were divided into high and low
socioeconomic status for the final analysis and missing data was excluded. See page 28.

A binomial logistic regression was performed to ascertain the effects of race on
the likelihood that sexual assault patients who present to the Emergency Department will
receive HIV/STI screening, treatment, or prophylaxis. All variables were nominal so tests
of linearity were not required. Further, there was no multicollinearity or significant
outliers. Of the four predictor variables only one was statistically significant: HIV test (as
shown in Table 5). Whites had 3 times higher likelihood to receive HIV tests than
Blacks/African Americans. None of the other variables were significant.
Table 5
Research Question 1: Binomial Logistic Regression Predicting Likelihood of Receiving
HIV/STI Screening Based on Race*
b
SE
Wald df
p
OR
95% CI
Lower
Upper
HIV(1)
-1.099 .523
4.413 1
.036
.333
.120
.929
White
* χ2(4) = 4.320, p < .05. Nagelkerke R2= 5 % Correctly classified 71% of cases.
Table 6
Research Question 2: Binomial Logistic Regression Predicting Likelihood of Receiving
Urinalysis or Pelvic Exam Based on Race*
b
SE
Wald df
p
OR
95% CI
Lower
Upper
Urinalysis .662
.432
2.347 1
.125
1.939
.831
4.522
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Pelvic
.140
.564
.062 1
.804
1.151
.381
3.478
Exam
Females
*Urine χ2(4) = 2.542, p < .05. Nagelkerke R2= 3 % Correctly classified 61% of cases.
Pelvic χ2(4) = .063, p < .05. Nagelkerke R2= 0 % Correctly classified 84% of cases.

Table 7
Research Question 3: Binomial Logistic Regression Predicting Likelihood of Receiving
Appropriate Drug Prophylaxis or Treatment Based on Race*
b
SE
Wald df
p
OR
95% CI
Lower
Upper
Medication -.358
.402
.795 1
.373
.699
.318
1.536
* χ2(4) = .796, p < .05. Nagelkerke R2= 0 % Correctly classified 56% of cases.
A binomial logistic regression was performed to ascertain the effects of
socioeconomic status on the likelihood that sexual assault patients who present to the
Emergency Department will receive HIV/STI screening, treatment, or prophylaxis. All
variables were nominal so tests of linearity were not required. Further, there was no
multicollinearity or significant outliers. Of the four predictor variables none were
statistically significant: HIV test (as shown in Table 9). was near significant and might
have been more so with a larger sample.
Table 8
Research Question 4: Binomial Logistic Regression Predicting Likelihood of Receiving
HIV/STI Screening Based on Socioeconomic Status *
b
SE
Wald
df
p
OR
95% CI
Lower
Upper
HIV(1)
1.489 .784 3.608
1
.057
4.432
.954
20.593
High SES
* χ2(4) = 5.586, p < .05. Nagelkerke R2= 6 % Correctly classified 87% of cases.
Table 9
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Research Question 5: Binomial Logistic Regression Predicting Likelihood of Receiving
Urinalysis or Pelvic Exam Based on Socioeconomic Status*
b
SE
Wald
df
p
OR
95% CI
Lower
Upper
Urine
-.502 .374 1.806
1
.179
.605
.291
1.259
Pelvic
-.291 .482
.365
1
.546
.747
.290
1.922
Exam
(Females)
*Urine χ2(4) = 3.111, p < .05. Nagelkerke R2= 3 % Correctly classified 62% of cases.
Pelvic χ2(4) = .063, p < .05. Nagelkerke R2= 3 % Correctly classified 62% of cases.

Table 10
Research Question 6: Binomial Logistic Regression Predicting Likelihood of Receiving
Drug Treatment or Prophylaxis Based on Socioeconomic Status
b
SE
Wald
df
p
OR
95% CI
Medication .101
.370
.075
1
.785
.904
Lower
Upper
.438
1.866

A binomial logistic regression was performed to ascertain the effects of
geographic region on the likelihood that sexual assault patients who present to the
Emergency Department will receive HIV/STI screening, treatment, or prophylaxis. All
variables were nominal so tests of linearity were not required. Further, there was no
multicollinearity or significant outliers. The Northeast was used as the reference
category. Of the four predictor variables only one was statistically significant: HIV test
(as shown in Table 11). Patients in the West had 8.7 times more likelihood to receive
HIV tests than patients in the Northeast, despite having 25% less cases. None of the other
variables were significant.
Table 11
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Research Question 7: Binomial Logistic Regression Predicting Likelihood of Receiving
HIV Test Based on Geographic Region*
b
SE
Wald df
p
OR
95%
CI
Lower
Upper
Northeast Reference
5.745
3
.125
West
2.161
1.088
3.944
1
.047 8.679 1.029
73.215
South
1.440
1.126
1.634
1
.201 4.219
.464
38.352
Midwest
1.156
1.106
10.475 1
.296 3.176
.363
27.759
* χ2(4) = 6.770, p < .05. Nagelkerke R2= 8% Correctly classified 87% of cases.

Table 12
Research Question 8: Binomial Logistic Regression Predicting Likelihood of Receiving
Urinalysis Based on Geographic Region*
b
SE
Wald
df
p
OR
95% CI
Lower
Upper
Northeast
1.904
3
.593
West
-.129 .504
.065
1
.788
.879
.328
2.359
South
-.470 .512
.843
1
.359
.625
.229
1.705
Midwest
-.550 .472 1.360
1
.244
.577
.229
1.454
* χ2(4) = 1.908, p < .05. Nagelkerke R2= 2% Correctly classified 62% of cases.

Table 13
Research Question 8: Binomial Logistic Regression Predicting Likelihood of Receiving
Pelvic Exam Based on Geographic Region*
b
SE
Wald
df
p
OR
95% CI
Lower
Upper
Northeast
3.179
3
.365
West
.264
.778
.115
1
.734
1.302
.284
5.977
South
.985
.721 1.866
1
.172
2.679
.652
11.011
Midwest
.154
.732
.044
1
.833
1.167
.278
4.900
* χ2(4) = 3.049, p < .05. Nagelkerke R2= 3% Correctly classified 85% of cases.

Table 14
Research Question 9: Binomial Logistic Regression Predicting Likelihood of Receiving
Appropriate Medications Based on Geographic Region*
b
SE
Wald
df
p
OR
95% CI
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Northeast
West
South

.489
.598

.508
.508

3.110
.929
1.382

3
1
1

.375
.335
.240

1.631
1.818

Lower

Upper

.603
.671

4.414
4.926

Midwest
-.029 .473
.004
1
.951
.971
.384
* χ2(4) = 3.140, p < .05. Nagelkerke R2= 3% Correctly classified 57% of cases.

2.455

A binomial logistic regression was performed to ascertain the effects of age group
on the likelihood that sexual assault patients who present to the Emergency Department
will receive HIV/STI screening, treatment, or prophylaxis. All variables were nominal so
tests of linearity were not required. Further, there was no multicollinearity or significant
outliers. Age 11-20 is the reference category. Of the four predictor variables only one was
statistically significant in any age group: appropriate medications. Age 0-10 was
statistically significant for 8 times less likelihood of receipt of appropriate medications
(as shown in Table 18). None of the other variables were significant in any age group.
Table 15
Research Question 10: Binomial Logistic Regression Predicting Likelihood of Receiving
HIV Test Based on Age Group
b
SE
Wald df
p
OR
95% CI
Lower
Upper
Age_New
2.772 4
.597
Age_New (1) -1.625 1.207 1.813 1
.178
.197
.019
2.096
Age_New(2)
-.074
.738
.010
1
.920
.929
.218
3.947
Age_New (3)
-.508
.799
.404
1
.525
.602
.126
2.880
Age_New (4)
-.654
.885
.546
1
.460
.520
.092
2.948
* χ2(4) = 3.445, p < .05. Nagelkerke R2= 4 % Correctly classified 87% of cases.
Table 16
Research Question 10: Binomial Logistic Regression Predicting Likelihood of Receiving
Urinalysis Based on Age Group
b
SE
Wald
df
p
OR
95% CI
Lower
Upper
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Age_New
3.701
4
.448
Age_New (1) -1.041 .690 2.281
1
.131
.353
.091
Age_New (2) -.606 .580 1.094
1
.296
.5454
.175
Age_New (3) -.147 .590
.062
1
.804
.864
.272
Age_New (4) -.588 .637
.852
1
.356
.556
.159
* χ2(4) = 3.808, p < .05. Nagelkerke R2= 3 % Correctly classified 62% of cases.

1.363
1.698
2.745
1.936

Table 17
Research Question 11: Binomial Logistic Regression Predicting
Likelihood of Receiving Pelvic Exams Based on Age Group
b

SE

Wald

df

p

OR

95% CI
Lower

Upper

Age_New
.715
4
.949
Age_New
.388 .935 .172
1
.678
1.474
.236
9.209
(1)
Age_New
.405 .840 .233
1
.629
1.500
.289
7.789
(2)
Age_New
.894 .001
1
.975
.972
.169
5.607
(3)
.028
Age_New
.154 .929 .028
1
.868
1.167
.189
7.207
(4)
* χ2(4) = .727, p < .05. Nagelkerke R2= .008 % Correctly classified 85% of cases.

Table 18
Research Question 11: Binomial Logistic Regression Predicting Likelihood of Receiving
Appropriate Medications Based on Age Group
b
SE
Wald
df
p
OR
95% CI
Lower
Upper
Age_New
14.750
4
.005
Age_New (1) -2.580 1.145 5.074
1
.024
.076
.008
.715
Age_New (2) .708 .588 1.447
1
.229
2.029
.641
6.425
Age_New (3) 1.061 .610 3.027
1
.082
2.889
.874
9.544
Age_New (4) .076 .645
.014
1
.907
1.078
.304
3.820
* χ2(4) = 28.02, p < .05. Nagelkerke R2= 21 % Correctly classified 65% of cases.

In summary, there is a statistically significant difference between white and black
races (independent variables) and receipt of HIV tests (dependent variable) among sexual
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assault survivors in the Emergency Department. There is not a statistically significant
difference between black and white races and urinalysis, pelvic exams, and appropriate
medications received among sexual assault survivors in the Emergency Department.
Further, there is not a statistically significant difference between high and low
SES (independent variable) and receipt of HIV tests, urinalysis, pelvic exams, and
appropriate medications (dependent variables) among sexual assault survivors in the
Emergency Department. Third, there is a statistically significant difference between
receipt of HIV tests among patients in the West compared to patients in the Northeast,
despite there being a greater number of sexual assaults in the Northeast. A patient in the
West has an 8.7 greater likelihood of receiving an HIV test than patients in the Northeast.
There were no other statistically significant differences based on geographic region.
A fourth significant difference found was the receipt of appropriate medications.
Patients age 0-10 had an 8 times lower likelihood of receiving appropriate medications
than patients in the reference group. There was not a statistically significant difference
between age and testing/screening/medications in other age groups.
In Section 4 the findings will be analyzed and interpreted. Limitations of the study
will be discussed. Recommendations for further research and practice will be made.
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Section 4: Application to Professional Practice and Implications for Social Change
The purpose of this research was to identify and describe factors that influence
whether sexual assault survivors were offered HIV/STI screening or testing, and/or
treatment/prophylaxis when they presented for care in hospital EDs. Only Black and
White races were used in the final sample where race was a variable because there was
not a large enough number of other races to perform regression. Subjects were divided
into two categories also for the purpose of binomial regression. Participants were placed
in the high socioeconomic status category if they had private insurance, Medicare, or
Worker’s Compensation insurance. They were categorized as low socioeconomic status if
they were self-pay, no charge, or had Medicaid. Geographic regions and age groups were
added to the independent variables because there seemed an opportunity for new
knowledge.
I then specifically looked at the influence of these races, socioeconomic statuses,
geographic regions, and ages on whether patients received HIV tests, urinalyses, pelvic
exams (females only), and appropriate medications. Medications were deemed
appropriate if they included drug classes commonly given to sexual assault victims as
part of protocol, specifically, antibiotics, anti-HIV, emergency contraception (females
only), or vaccines. That is not to say that other medications given were not appropriate
for some other aspect of patient care.
Interpretation of the Findings
An underlying assumption of this study was that sexual assault is a risk factor for
acquiring sexually transmitted infections and both are serious public health problems.
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Further, use of HIV screening/testing and prophylaxis has been found to be low in the
general ED and the subset sexual assault population (Ende et al., 2008; Merchant &
Catanzaro, 2009; Rothman et al., 2011). Specifically, Ende et al. (2008) found that 65%
of sexual assault survivors received screening and prophylaxis in New York State EDs.
Merchant and Catanzaro (2009) found that 20% of their NHAMCS sample of sexual
assault patients received HIV testing.
In the current study, I found that 13.2% of the total sample received HIV
screening and 12.6 % received prophylaxis. This seems to confirm underuse of HIV
screening/testing and/or prophylaxis in the ED and among sexual assault patients.
DuMont et al. (2017) concluded that services were not extended to all sexual assault
patients. That may be a reason for the small percentages found in the current study. It is
possible that some procedures or medications were not appropriate based on age or other
characteristics. Barriers surrounding medication acceptance and compliance (Dejelaj et
al., 2017) may have also had an impact on this study. Finally, patients may choose not to
partake of services, which influences results. Amey and Bishai (2012) set a precedent for
studying the quality of services extended to female victims of sexual assault. Their study
was the inspiration for the current study. Amey and Bishai (2012) found that Black
women received more services.
In the current study, I extended the knowledge base in the discipline by including
men and did not find a difference in services received between Black and White except
for HIV testing, which was higher in White individuals. This seems to be a contradiction
of Amey and Bishai’s (2012) findings and the general findings of Lo et al. (2018) who
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observed higher rates of HIV testing in Blacks than in Whites in the general population.
A further expansion of knowledge was found in the current study by adding SES, region,
and age as independent variables. Although the other services studied were underused,
there was not a statistically significant difference in care associated with race or SES.
Interpretation of Findings by Research Question
RQ1 addressed whether there was a statistically significant difference between
races (independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED. The null hypothesis was rejected because White people had a
3 times higher likelihood of receiving an HIV test after sexual assaults than did Black
people. As noted in the previous section, this is a contradiction to previous findings that
indicated Blacks had a greater likelihood to receive HIV tests in general and after sexual
assault in particular.
RQ2 addressed whether there was a statistically significant difference between
races (independent variable) and receipt of urine tests and/or pelvic exams (dependent
variables) to diagnose sexually transmitted infections among sexual assault survivors in
the ED. The null hypothesis was accepted because there were no statistically significant
relationships found.
RQ3 addressed whether there was a statistically significant difference between
races (independent variable) and receipt of HIV/STI medication treatment or prophylaxis
(dependent variable) among sexual assault survivors in the ED. The null hypothesis was
true because there was no statistically significant relationship found.
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RQ4 addressed whether there was a statistically significant difference between
SES (independent variable) and receipt of HIV tests (dependent variable) among sexual
assault survivors in the ED. The null hypothesis was true because there was no
statistically relationship between variables. This is most likely because the number of
people receiving HIV tests in the entire sample was only 21, and some patients were
excluded because there was not enough socioeconomic information.
RQ5 addressed if there was a statistically significant difference between
socioeconomic status (independent variable) and receipt of urine tests and/or pelvic
exams to diagnose sexually transmitted infections (dependent variable) among sexual
assault survivors in the Emergency Department. The null hypothesis was accepted that
there was no significant difference.
The same was true for RQ6 about if there was a statistically significant difference
between socioeconomic status (independent variable) and HIV/STI medication treatment
or prophylaxis received (dependent variable) among sexual assault survivors in the ED.
The answer was no, so the null hypothesis was accepted.
RQ7 addressed whether there was a statistically significant difference between
geographic region (independent variable) and receipt of HIV tests (dependent variable)
among sexual assault survivors in the ED. The null hypothesis was rejected because
patients in the West received HIV tests 8.7 times more than the Northeast despite having
a lower number of sexual assault patients.
RQ8 addressed whether there was a statistically significant difference between
geographic region (independent variable) and receipt of urinalysis or pelvic exam
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(dependent variable) among sexual assault survivors in the ED. The null hypothesis was
accepted because there was not a statistically significant difference. The null hypothesis
was also accepted for RQ9, which addressed whether there was a statistically significant
difference between geographic region (independent variable) and receipt of appropriate
medications (dependent variable) among sexual assault survivors in the ED.
RQ10 addressed whether there was a statistically significant difference between
age (independent variable) and receipt of urinalysis or pelvic exam (dependent variable)
among sexual assault survivors in the ED. The null hypothesis was true because there
was no significant relationship.
RQ11 addressed whether age and receipt of appropriate medications was
significant among sexual assault survivors in the ED. The null hypothesis was rejected
because patients between ages 0 and 10 had an 8 times lower likelihood to receive
appropriate medications than the reference group. This may be because the sample were
children for whom some medications may not be appropriate or approved.
Limitations
Limitations of all studies of sexual assault include difficulty identifying victims.
This was also a limitation of the current study and resulted in a small sample size and a
possible threat to validity related to selection of the sample. Participants were identified
as sexual assault survivors by ICD 9 codes, 58300 adult sexual abuse, 58301 child sexual
abuse, V71.5 observation after alleged rape or sexual assault, and E code 9601 rape. It is
possible that some sexual assault patient records were not coded as such, but rather as
other injuries they may have presented with. Another limitation was that there were not
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enough nonwhite and nonblack patients to perform regression, and they were excluded
from the final analysis because the sample size of 122 still had adequate power.
The assignment of high or low SES assumed that private insurance, Medicare, and
Worker’s Compensation patients had higher income than self-pay, no charge, and
Medicare patients. This may impact validity as there may be more effective ways to
determine SES. The blank, unknown, and other categories were excluded. The sample
size of 126 still had adequate power. The main threats to reliability are sampling errors
that occurred in the original database and missing race and/or socioeconomic status data.
As the current study was specific to sexual assault patients in EDs, it is not generalizable
to other populations. As this was a cross sectional study, and I studied a given point in
time, causality cannot be proven. A common use is to identify risk factors, which I did in
this study. The study can still be useful when assessing the health needs of populations.
The study also affords the opportunity to develop hypotheses about cause as long as
threats of bias are evaluated. Uncertainty regarding the order of causation depends on the
cause and how it is measured.
Recommendations
Recommendations inspired by the current study include further research with
larger sample sizes. This could help to determine the full extent of services offered to
sexual assault survivors in the EDs of US hospitals. This study looked at only four of
many recommended services. Another benefit of a larger sample size would be to include
more races and the ability to confirm or reject previous findings such as Amey and Bishai
(2012) and Lo, Runnels, and Cheng (2018).
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Further, this study only looks at whether the service was given and does not
reflect if it was offered and refused or inappropriate for some other reason. Knowing
whether patients accepted or declined services offered would be helpful in determining
whether there are barriers to acceptance. Knowing whether patients were appropriate for
services would help determine whether there is a knowledge deficit among care
providers. These observations could also influence the design and implementation of
interventions on the socioecological level where they would be most effective. It would
be interesting to determine whether services are more consistently offered across race,
socioeconomic, age, and geographic regions in hospitals that use a standardized protocol
or specially trained staff such as Forensic Nurse Examiners. While conventional wisdom
seems to support the notion that it does, some previous studies suggest it does not
(Draughon, Anderson, Hansen, & Sheridan, 2014). The NHAMCS would be a good data
base to use for that inquiry.
Implications for Professional Practice and Social Change
Professional Practice
Standardizing terms, definitions, and reporting requirements across all law
enforcement, healthcare, government, and social science disciplines would improve
further research into the experience of sexual assault survivors. This would improve
documentation, the ability to collect and compare data during research of all disciplines.
Criminal justice statistics, medical records, and injury reporting that was comparable on
local, state, and national levels would enhance the ability to do research within this
vulnerable population without putting a further burden on them. In NHACMS data,
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specifically ensuring the correct ICD code for suspected or alleged sexual assault/abuse is
documented in all cases would help to identify patients for future research. Including
male victims in all studies of sexual assault will help to collect more data on a segment of
the population where there is currently little knowledge available.
It is generally accepted that standardized protocols help to ensure safer care and
better communication among caregivers. Evidence based protocols and guides are known
since the 1990’s to improve patient outcomes, promote high quality care, improve
medicolegal robustness, and reduce costs. They also provide a metric architecture for
future quality and other assessments.
Specialized protocols for sexual assault exist as do specially trained forensic nurse
examiners and other professionals who carry them out. It isn’t known if any of the
participating hospitals had protocols for the management of sexual assault patients,
however it behooves one to wonder whether the results of the current study would be
found if a standard protocol was in place? All hospitals could study their community
level data to determine whether there are any discrepancies in the way protocols are being
carried out and why.
Further, this study can have all caregivers question whether we have preconceived
notions that affect our judgement when using optional risk-based guidelines over routine
screening for HIV. How do our posture, attitude, and presentation of facts when offering
HIV screening and/or prophylaxis convey our feelings about race, socioeconomic status,
sexual assault, and/or the acceptance of HIV screening/prophylaxis? Do these things
influence whether a patient accepts?

53
Positive Social Change
A positive social change that could occur as the result of this study would be
improved care of survivors of sexual assault as it relates to HIV/STI screening/testing and
prophylaxis. A caregiver who is aware that discrepancies in services can occur may
incorporate offering HIV screening on the individual level into their patient routine. That
caregiver can also promote the use of standardized protocols and specialized staff in the
hospital community level. This could eventually result in decreased rate of HIV
transmission in the community. That in turn could decrease the cost of HIV and sexual
assault aftercare on the community and societal level.
Another positive social change that could occur as a result of the application of
this study is less social stigma for sexual assault victims. A standardized protocol that
makes HIV screening a routine does not single out any one person or group or make
value judgements. Early identification is often hindered by stigma, but a protocol reduces
the risk, by letting patients know it is a part of comprehensive health care.
Finally, contributing to the knowledge base about sexual assault victims
contributes to positive social change. Increased awareness of the challenges of sexual
assault victims that filters up to the policy making level can help to influence the priority
given to research funds, the enactment and enforcement of laws, and the support of
evidence-based interventions.
Conclusion
This study has provided important information about the care and services
provided to sexual assault patients in United States EDs. Specifically, a white patient has
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a 3 times greater likelihood of receiving HIV testing than a black person. Patients in the
Northeast have an 8.7 times lower likelihood to receive an HIV test than patients in other
geographic regions, despite a greater number of sexual assault patients. Patients in the
age group of 0-10 have an 8 times lower likelihood of receiving appropriate medications
than the reference category. This is important new information that contributes to and
fills gaps in the knowledge base for the care of sexual assault victims in US Hospital EDs
and suggests hypotheses for future research.
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